Will be an interesting one to watch, I suspect this treatment (if successful in trials) will extend beyond COVID-19:
'MGC's formulation, 'ArtemiC', is a formula based on Artemisinin and Curcumin, which are well-known natural active ingredients with anti-infective properties. The Drug was designed to target viral inflammatory infections, though the effects of the drug are now being investigated on novel coronavirus 2019 (SARS-CoV-2) infected patients in a double-blind placebo-controlled, Phase II clinical trial to be held at the Israel hospital.'
The treatment may be used for other conditions and I'm sure this is being considered by MGC.
'MGC's ArtemiC is currently sold and categorized as a food supplement or nutraceutical product, requiring no new approvals or licenses.....'
A quote from Roby:
"We are anticipating the ability to produce and sell ArtemiC within a short period of time following successful completion of the Trial".
Given the quick turn around, if the treatment proves successful we can quickly move into commercialisation. Definitely less costs associated (i.e. research, production, licences, etc) with this treatment than medicinal cannabis medications in general.
Time will tell but the potential is definitely there (if trials are successful).
https://thegreenfund.com/mgc-pharma...vwo_notification_1588259587&vwo_powered=1
- Forums
- ASX - By Stock
- Ann: Phase II Clinical Trial on COVID-19 Patients Commenced
Will be an interesting one to watch, I suspect this treatment...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
35.0¢ |
Change
0.015(4.48%) |
Mkt cap ! $16.94M |
Open | High | Low | Value | Volume |
34.5¢ | 35.5¢ | 33.0¢ | $60.95K | 174.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11855 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 1338 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11855 | 0.270 |
1 | 20000 | 0.250 |
1 | 2200 | 0.230 |
1 | 14600 | 0.205 |
2 | 17358 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 1338 | 1 |
0.390 | 14 | 1 |
0.400 | 6621 | 3 |
0.415 | 225 | 1 |
0.420 | 147 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online